adenosine diphosphate has been researched along with Stroke in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 17 (39.53) | 29.6817 |
2010's | 21 (48.84) | 24.3611 |
2020's | 5 (11.63) | 2.80 |
Authors | Studies |
---|---|
Herbert, JM; Savi, P | 1 |
Grewal, AK; Khan, H; Singh, TG; Tiwari, P | 1 |
Brand, ART; de Borst, GJ; Korporaal, SJA; Leunissen, TC; Pasterkamp, G; Roest, M; Urbanus, RT; van Vriesland, D | 1 |
Collins, DR; Coughlan, T; Cox, D; Egan, B; Lim, ST; Lim, SY; McCabe, DJH; McCarthy, AJ; Murphy, SJX; Murphy, SM; O'Neill, D; Smith, DR; Tierney, S | 1 |
Gager, GM; Hengstenberg, C; Jilma, B; Kolesnik, E; Lang, IM; Prüller, F; Siller-Matula, JM; Toma, A; von Lewinski, D; Wallner, M; Winter, MP | 1 |
Guo, Y; He, D; Luo, X; Qu, W; Wu, L; Yu, Z; Zhang, Y; Zhao, J | 1 |
Cao, Y; Dong, K; Liu, L; Rao, Z; Wang, A; Wang, F; Wang, Y; Zhao, X; Zheng, H | 1 |
Ding, Y; Du, H; Fredrickson, V; Fu, P; Geng, X; Guthikonda, M; Hüttemann, M; Ji, X; Ling, F; Meng, R; Peng, C; Sy, C; Tan, X | 1 |
Ding, YL; Gu, ZQ; Tan, J; Yang, J; Zhao, HD; Zou, JJ | 1 |
Bagoly, Z; Csiba, L; Kappelmayer, J; Magyar, T; Muszbek, L; Pongrácz, E; Sarkady, F | 1 |
Cha, JK; Choi, JH; Huh, JT | 1 |
Arroyo, AB; Bernal, A; Guiú, IS; Iniesta, JA; Jover, E; Lozano, ML; Martínez, C; Rivera, J; Rodríguez, JM; Vicente, V | 1 |
Bacchi Reggiani, ML; Dall'Ara, G; Gallo, P; Ghetti, G; Marrozzini, C; Marzocchi, A; Moretti, C; Palmerini, T; Rapezzi, C; Saia, F; Taglieri, N | 1 |
Bachelot-Loza, C; Dreano, E; Lechaftois, M; Lerouet, D; Marchand-Leroux, C; Margaill, I; Palmier, B | 1 |
Deguchi, I; Fukuoka, T; Hayashi, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagamine, Y; Ohe, Y; Sano, H; Sehara, Y; Tanahashi, N | 1 |
Yang, J; Yang, ZH; Zhang, YD; Zhao, HD; Zhao, YX; Zhou, JS; Zou, JJ | 1 |
Jakubowski, JA; Mizuno, M; Ohno, K; Sugidachi, A; Tomizawa, A | 1 |
An, LX; Dong, Q; Guan, YT; Han, Y; Jiang, JM; Li, L; Li, SX; Liu, X; Luo, Z; Lv, HH; Wu, S; Xu, JF; Yang, XL; Zheng, SL | 1 |
Chen, X; Chu, S; Fang, W; Fei, Y; He, G; Li, Y; Wang, D; Wang, S; Wu, Q; Yang, L | 1 |
Cha, JK; Choi, JH; Huh, JT; Kang, MJ; Kim, DH; Nah, HW; Park, HS; Suh, HK | 1 |
Cha, JK; Jeon, HW; Kang, MJ | 1 |
Goodall, AH; Hayes, PD; Jones, CI; McMahon, GS; Naylor, AR; Webster, SE | 1 |
Chomel, JC; Godeneche, G; Macchi, L; Neau, JP; Ragot, S; Sorel, N | 1 |
Ionova, VG; Petrova, MM; Savchenko, AA; Shimohina, NY; Smertina, EG; Tanashyan, MM | 1 |
Deguchi, I; Dembo, T; Fukuoka, T; Furuya, D; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Takeda, H; Tanahashi, N | 1 |
Gnyawali, S; Khanna, S; Peterson, L; Rink, C | 1 |
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Migliorini, A; Parodi, G; Valenti, R | 1 |
Bakdash, S; Bhatt, DL; Depta, JP; Fowler, J; Katzan, I; Kottke-Marchant, K; Novak, E | 1 |
He, BS; Tan, J; Yang, J; Zhou, JS; Zou, JJ | 1 |
Ding, Y; Geng, X; Guthikonda, M; Higashida, T; Hüttemann, M; Kochanski, R; Peng, C | 1 |
Bitanga, ES; Florento, L; Gan, R; Teleg, RA | 1 |
Malinin, AI; Sane, DC; Serebruany, VL | 1 |
Hillarp, A; Lethagen, S; Mattiasson, I | 1 |
Bae, HR; Cha, JK; Ho, JM; Jo, WS; Kim, JW; Shin, HC | 1 |
Feijge, MA; Giesen, PL; Heemskerk, JW; Huijberts, M; van der Meijden, PE; van Raak, LP | 1 |
Brown, MM; Harrison, P; Lawrie, AS; Machin, SJ; Mackie, IJ; McCabe, DJ; Purdy, G; Sidhu, PS | 1 |
Andrew, ME; Ben-Shlomo, Y; Beswick, AD; Elwood, PC; Sharp, DS | 1 |
Fang, Q; Mayhan, WG; Molacek, E; Patel, KP; Sun, H; Zheng, H | 1 |
Daniel, WG; Fateh-Moghadam, S; Garlichs, C; Gawaz, M; Geisler, T; Handschu, R; Htun, P; Langer, H; Sander, D; Stellos, K; Tomandl, B; Walton, K | 1 |
Cleanthis, M; Smout, J; Stansby, G | 1 |
Andrews, RK; Arthur, JF; Berndt, MC; Gardiner, EE; Kenny, D | 1 |
Beswick, A; Elwood, PC; Flower, RJ; McCarron, P; O'Brien, JR; Pickering, J; Renaud, SR | 1 |
Chen, CJ; Chen, SY; Chen, WY; Chiang, AN; Kao, TK; Liao, SL; Ou, YC; Wang, CC | 1 |
4 review(s) available for adenosine diphosphate and Stroke
Article | Year |
---|---|
P2Y12, a new platelet ADP receptor, target of clopidogrel.
Topics: Adenosine Diphosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Down-Regulation; Humans; Membrane Proteins; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine | 2003 |
Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.
Topics: Adenosine Diphosphate; Animals; Enzyme Inhibitors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Ribose; Stroke | 2022 |
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention.
Topics: Adenosine Diphosphate; Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug; Global Health; Humans; Incidence; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Period; Risk Factors; Stroke; Ticlopidine | 2014 |
Platelet receptor redox regulation.
Topics: Adenosine Diphosphate; Animals; Antioxidants; Blood Platelets; CD36 Antigens; Collagen; Cytoplasm; Dimerization; Heart Diseases; Hemostasis; Humans; NADPH Oxidases; Oxidation-Reduction; Platelet Aggregation; Protein Structure, Tertiary; Quercetin; Signal Transduction; Stroke; Superoxides; Thrombosis | 2008 |
5 trial(s) available for adenosine diphosphate and Stroke
Article | Year |
---|---|
Relationship between smoking and responsiveness to clopidogrel in non-cardiogenic ischemic stroke patients.
Topics: Adenosine Diphosphate; Aged; Blood Coagulation Tests; Clopidogrel; Drug Resistance; Female; Humans; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Smoking; Stroke; Ticlopidine | 2014 |
Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Arachidonic Acid; Aspirin; Carotid Artery Diseases; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2009 |
Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.
Topics: Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Female; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prospective Studies; Stroke | 2009 |
Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Aryldialkylphosphatase; Asian People; Clopidogrel; Female; Genotype; Humans; Linear Models; Male; Mass Spectrometry; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stroke; Ticlopidine; Young Adult | 2012 |
Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
Topics: Adenosine Diphosphate; Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Capsules; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Stroke; Time Factors | 2003 |
34 other study(ies) available for adenosine diphosphate and Stroke
Article | Year |
---|---|
Flow Cytometry Based Platelet Reactivity Testing to Predict the Occurrence of Per-operative Solid Microemboli During Carotid Endarterectomy.
Topics: Adenosine Diphosphate; Carotid Stenosis; Embolism; Endarterectomy, Carotid; Flow Cytometry; Humans; Intracranial Embolism; Stroke; Ultrasonography, Doppler, Transcranial | 2022 |
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Ischemia; Dipyridamole; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Stroke | 2022 |
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Cardiovascular Diseases; Clopidogrel; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prognosis; Proportional Hazards Models; Prospective Studies; Secondary Prevention; Stroke; Survival Rate; Ticagrelor | 2020 |
Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke.
Topics: Adenosine Diphosphate; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Thrombelastography; Treatment Outcome | 2022 |
High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Factors; Stroke; Thrombelastography; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Synergetic neuroprotection of normobaric oxygenation and ethanol in ischemic stroke through improved oxidative mechanism.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain; Brain Ischemia; Combined Modality Therapy; Disease Models, Animal; Ethanol; Neuroprotective Agents; Oxygen Inhalation Therapy; Rats; Reactive Oxygen Species; Stroke; Treatment Outcome | 2013 |
CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Asian People; China; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; DNA; Female; Genotype; Humans; Isoenzymes; Linear Models; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stroke; Ticlopidine; Young Adult | 2013 |
Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.
Topics: Adenosine Diphosphate; Adult; Aged; Alprostadil; Blood Platelets; Cell Adhesion Molecules; Clinical Laboratory Techniques; Clopidogrel; Female; Flow Cytometry; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Reproducibility of Results; Stroke; Ticlopidine | 2013 |
Adenosine diphosphate-induced platelet aggregation might contribute to poor outcomes in atrial fibrillation-related ischemic stroke.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Female; Hospitalization; Humans; Logistic Models; Male; Multivariate Analysis; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2014 |
High on-treatment platelet reactivity in patients with ischemic cerebrovascular disease: assessment of prevalence and stability over time using four platelet function tests.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Blood Platelets; Cell Adhesion Molecules; Cells, Cultured; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Receptors, Purinergic P2Y12; Stroke; Ticlopidine; Time Factors | 2014 |
Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?
Topics: Adenosine Diphosphate; Blood Platelets; Female; Humans; Male; Phenanthrenes; Platelet Aggregation; Platelet Aggregation Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Receptors, Purinergic P2Y12; Stroke | 2014 |
ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Asian People; ATP Binding Cassette Transporter, Subfamily B; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; DNA Methylation; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Promoter Regions, Genetic; Stroke; Ticlopidine; Young Adult | 2015 |
Prasugrel reduces ischaemic infarct volume and ameliorates neurological deficits in a non-human primate model of middle cerebral artery thrombosis.
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Haplorhini; Hemorrhage; Infarction, Middle Cerebral Artery; Macaca fascicularis; Male; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Stroke; Thrombosis; Time Factors | 2015 |
Comparison of VerifyNow P2Y12 and thrombelastography for assessing clopidogrel response in stroke patients in China.
Topics: Adenosine Diphosphate; Aged; Brain Ischemia; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Stroke; Thrombelastography; Ticlopidine | 2016 |
N2 extenuates experimental ischemic stroke through platelet aggregation inhibition.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Arteriovenous Shunt, Surgical; Blood Coagulation; Brain; Brain Ischemia; Edema; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Female; Imidazoles; Male; Maze Learning; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Stroke; Thrombosis; Thromboxane A2; Vanillic Acid | 2015 |
High residual platelet reactivity (HRPR) for adenosine diphosphate (ADP) stimuli is a determinant factor for long-term outcomes in acute ischemic stroke with anti-platelet agents: The meaning of HRPR after ADP might be more prominent in large atherosclero
Topics: Adenosine Diphosphate; Atherosclerosis; Brain Ischemia; Cohort Studies; Endpoint Determination; Follow-Up Studies; Humans; Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prognosis; Stroke; Treatment Outcome | 2016 |
ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Aspirin; Brain Ischemia; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2008 |
Platelet aggregation and endothelial function in patients with complicated essential hypertension (ischemic stroke) and coronary heart disease.
Topics: Adenosine Diphosphate; Coronary Disease; Endothelium, Vascular; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation; Statistics, Nonparametric; Stroke; von Willebrand Factor | 2010 |
Evaluation of clopidogrel resistance in ischemic stroke patients.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Drug Resistance; Female; Humans; In Vitro Techniques; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2011 |
Oxygen-inducible glutamate oxaloacetate transaminase as protective switch transforming neurotoxic glutamate to metabolic fuel during acute ischemic stroke.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Aspartate Aminotransferase, Cytoplasmic; Aspartate Aminotransferases; Brain; Cell Survival; Cells, Cultured; Glutamic Acid; Hypoxia; Immunohistochemistry; In Vitro Techniques; Magnetic Resonance Imaging; Mice; Oxygen; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Stroke | 2011 |
High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angioplasty; Aspirin; Clopidogrel; Death; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Risk; Stents; Stroke; Thrombosis; Ticlopidine | 2011 |
Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Proportional Hazards Models; Secondary Prevention; Stroke; Survival Analysis; Ticlopidine; Treatment Outcome | 2012 |
Neuroprotection conferred by post-ischemia ethanol therapy in experimental stroke: an inhibitory effect on hyperglycolysis and NADPH oxidase activation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Behavior, Animal; Blood Glucose; Brain Chemistry; Brain Ischemia; Central Nervous System Depressants; Cerebral Infarction; Ethanol; Glucose Transporter Type 1; Glucose Transporter Type 3; Glycolysis; L-Lactate Dehydrogenase; Lactic Acid; Male; NADPH Oxidases; Neuroprotective Agents; Phosphofructokinases; Rats; Rats, Sprague-Dawley; Stroke | 2013 |
Effect of increasing doses of aspirin on platelet aggregation among stroke patients.
Topics: Adenosine Diphosphate; Adult; Aspirin; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke | 2002 |
Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke?
Topics: Adenosine Diphosphate; Aspirin; Female; Humans; Male; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke | 2003 |
Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Antigens, CD; Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Collagen; Female; Flow Cytometry; Heparin; Humans; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; P-Selectin; Patient Selection; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Stroke; Tetraspanin 30; Ticlopidine; Time Factors | 2004 |
Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
Topics: Adenosine Diphosphate; Adult; Aged; Blood Platelets; Calcium Signaling; Case-Control Studies; Clopidogrel; Diabetes Mellitus, Type 2; Humans; In Vitro Techniques; Membrane Proteins; Middle Aged; Phosphatidylserines; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Thrombin; Thrombosis; Ticlopidine | 2005 |
Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; Blood Platelets; Case-Control Studies; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance; Epinephrine; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prostaglandin-Endoperoxide Synthases; Stroke; von Willebrand Factor | 2005 |
Platelet aggregation in whole blood is a paradoxical predictor of ischaemic stroke: Caerphilly Prospective Study revisited.
Topics: Adenosine Diphosphate; Blood Coagulation Tests; Blood Platelets; Brain Ischemia; Causality; Cohort Studies; Humans; Male; Middle Aged; Models, Statistical; Pilot Projects; Platelet Aggregation; Platelet Count; Prospective Studies; Risk Factors; Sensitivity and Specificity; Stroke; Wales | 2005 |
Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles.
Topics: Acetophenones; Acetylcholine; Acridines; Adenosine Diphosphate; Alcohol Drinking; Alcohols; Animals; Blotting, Western; Body Weight; Central Nervous System Depressants; Cerebral Arteries; Cerebrovascular Circulation; Dilatation, Pathologic; Enzyme Inhibitors; Luminescence; Male; Models, Statistical; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitroglycerin; Phosphoproteins; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Superoxides; Time Factors; Up-Regulation; Vasodilation; Vasodilator Agents | 2006 |
Hyperresponsiveness of platelets in ischemic stroke.
Topics: Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Biomarkers; Blood Platelets; Brain Ischemia; Collagen; Epinephrine; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Predictive Value of Tests; Recurrence; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Stroke; Time Factors | 2007 |
Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; Epinephrine; Humans; Ischemic Attack, Transient; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Recurrence; Stroke; Time Factors | 2008 |
Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study.
Topics: Adenosine Diphosphate; Aged; Blood Coagulation Tests; Electric Impedance; Filtration; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation; Predictive Value of Tests; Risk; Stroke; Time Factors; Wales | 2001 |
Opioids modulate post-ischemic progression in a rat model of stroke.
Topics: Amidines; Analgesics, Opioid; Animals; Benzamides; Brain; Brain Ischemia; Cytoprotection; Disease Models, Animal; Disease Progression; Dynorphins; Encephalitis; Immune Tolerance; Interleukin-6; Male; Narcotic Antagonists; Neuroprotective Agents; Peptide Fragments; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Stroke | 2008 |